Newest figures come from the 10-Q for Q1 FY2026, filed May 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EZRAW SEC filings page.
Reliance Global Group, Inc. Series A Warrants (EZRAW) reported $12.4M in revenue for fiscal year 2025, down 11.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business is shrinking at the top line while overhead rises, and balance-sheet repair has not stopped operating cash losses.
FY2025’s net loss of$6.99M accompanied operating cash flow of-$3.09M and free cash flow of-$3.11M , so accounting losses are translating into cash consumption rather than being mainly non-cash. At the same time, liabilities fell50.3% and long-term debt fell57.1% from FY2024, indicating deleveraging through contraction rather than growth funded by the operation.
Revenue fell
Capital expenditures were only
Financial Health Signals
We do not publish a peer-relative financial health score for Reliance Global Group, Inc. Series A Warrants, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Reliance Global Group, Inc. Series A Warrants passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Reliance Global Group, Inc. Series A Warrants reported a net loss of $7.0M while operations used $3.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Reliance Global Group, Inc. Series A Warrants reported an operating loss of $9.0M against $1.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Reliance Global Group, Inc. Series A Warrants generated $3.8M in revenue in Q1 2026. This represents a decrease of 9.7% from the same quarter a year earlier. Against the prior quarter it is up 46.5%.
Reliance Global Group, Inc. Series A Warrants's EBITDA was -$935K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Reliance Global Group, Inc. Series A Warrants reported a net loss of $1.5M in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Reliance Global Group, Inc. Series A Warrants earned -$0.09 per diluted share (EPS) in Q1 2026.
Cash & Balance Sheet
Reliance Global Group, Inc. Series A Warrants held $2.3M in cash against $3.9M in long-term debt as of Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Reliance Global Group, Inc. Series A Warrants's operating margin was -32.4% in Q1 2026, reflecting core business profitability. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.1 percentage points.
Reliance Global Group, Inc. Series A Warrants's net profit margin was -38.4% in Q1 2026, showing the share of revenue converted to profit. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.5 percentage points.
Reliance Global Group, Inc. Series A Warrants's quarterly ROE was -19.8% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is up 46.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Not reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
EZRAW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M-9.7% | $2.6M-20.8% | $2.5M-27.5% | $3.1M-4.5% | $4.2M+3.8% | $3.3M-0.7% | $3.4M+5.1% | $3.2M+1.2% |
| SG&A Expenses | $1.4M-10.5% | $781K-24.3% | $1.1M+36.4% | $1.5M+50.5% | $1.5M+10.3% | $1.0M-2.5% | $822K-23.1% | $992K-11.9% |
| Operating Income | -$1.2Mn/m | -$1.3Mn/m | -$3.9Mn/m | -$2.4Mn/m | -$1.4Mn/m | -$1.0Mn/m | -$512Kn/m | -$1.1Mn/m |
| EBITDA | -$935Kn/m | -$1.0Mn/m | -$3.6Mn/m | -$2.0Mn/m | -$1.0Mn/m | -$645Kn/m | -$90Kn/m | -$677Kn/m |
| Income Tax | $0n/m | N/A | $0n/m | N/A | $0n/m | N/A | $0n/m | $0n/m |
| Net Income | -$1.5Mn/m | -$1.4Mn/m | -$1.2Mn/m | -$2.7Mn/m | -$1.7Mn/m | -$1.4Mn/m | -$837Kn/m | -$1.5Mn/m |
| EPS (Basic) | -$0.09 | N/A | -$0.20 | -$0.85 | -$0.66 | N/A | -$0.67 | -$2.76 |
| EPS (Diluted) | -$0.09 | N/A | -$0.20 | -$0.85 | -$0.66 | N/A | -$0.67 | -$2.76 |
| Diluted Shares (Avg) | 17M | N/A | 6M | 3M | 3M | N/A | 1M | 539,133 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.
EZRAW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.8M-18.0% | $13.5M-21.8% | $15.7M-10.1% | $18.0M-1.8% | $16.8M-4.1% | $17.3M-24.8% | $17.4M-45.1% | $18.3M-47.4% |
| Current Assets | $4.5M+15.9% | $4.3M+7.1% | $5.0M+30.8% | $7.1M+64.5% | $3.9M+12.9% | $4.0M-8.9% | $3.8M-18.4% | $4.3M-39.4% |
| Cash & Equivalents | $2.3M+485.5% | $1.3M+253.0% | $2.6M+179.0% | $2.0M+39.2% | $388K-42.9% | $373K-72.0% | $925K-47.9% | $1.4M+10.3% |
| Goodwill | $4.8M-28.5% | $4.8M-28.5% | $5.6M-16.9% | $5.6M-16.9% | $6.7M0.0% | $6.7M0.0% | $6.7M-53.2% | $6.7M-53.2% |
| Total Liabilities | $6.4M-55.2% | $7.1M-50.3% | $8.9M-39.0% | $14.9M-3.4% | $14.2M-8.8% | $14.3M-9.8% | $14.6M-18.2% | $15.5M-29.3% |
| Current Liabilities | $1.9M-52.6% | $2.4M-32.9% | $3.4M+0.5% | $5.0M+34.9% | $3.9M+11.2% | $3.6M+12.0% | $3.4M-12.8% | $3.7M-23.5% |
| Non-Current Liabilities | $4.5M-56.1% | $4.7M-56.0% | $5.5M-51.0% | $9.9M-15.6% | $10.3M-14.6% | $10.7M-15.3% | $11.2M-19.7% | $11.7M-30.9% |
| Long-Term Debt | $3.9M-56.7% | $4.1M-57.1% | $4.6M-53.0% | $8.6M-16.1% | $9.1M-15.1% | $9.5M-14.1% | $9.9M-13.1% | $10.3M-12.1% |
| Total Equity | $7.4M+183.5% | $6.4M+114.4% | $6.7M+139.1% | $3.1M+6.7% | $2.6M+33.4% | $3.0M-58.1% | $2.8M-79.7% | $2.9M-77.8% |
| Retained Earnings | -$56.5Mn/m | -$55.1Mn/m | -$53.7Mn/m | -$52.5Mn/m | -$49.8Mn/m | -$48.1Mn/m | -$46.7Mn/m | -$45.8Mn/m |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments.
EZRAW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$571K-388.7% | -$1.6Mn/m | -$814Kn/m | -$853Kn/m | $198Kn/m | -$867Kn/m | -$758K-138.1% | -$685Kn/m |
| Depreciation & Amortization | $304K-15.6% | $311K-13.6% | $314K-25.6% | $346K-26.3% | $361K-32.5% | $360K-52.5% | $422K-35.4% | $470K-28.3% |
| Stock-Based Compensation | $16K-98.4% | N/A | $2.7M+21329.2% | N/A | $975K+5151.5% | N/A | $13K-54.0% | $246K+594.9% |
| Capital Expenditures | N/A | $0-100.0% | $6K+74.5% | $4K+37.2% | $5K-56.9% | $5K+214.5% | $4K-55.5% | $3K-51.1% |
| Free Cash Flow | N/A | -$1.6Mn/m | -$821Kn/m | -$857Kn/m | $193Kn/m | -$872Kn/m | -$762K-138.5% | -$688Kn/m |
| Investing Cash Flow | -$500Kn/m | $1.0Mn/m | $4.3Mn/m | -$12Kn/m | -$15Kn/m | -$24Kn/m | -$22Kn/m | -$7K-100.9% |
| Financing Cash Flow | $1.6Mn/m | -$185K-155.2% | -$3.4M-1158.9% | $2.4M+74.1% | -$169Kn/m | $336K-14.1% | $319Kn/m | $1.4Mn/m |
| Dividends Paid | $131K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Share Buybacks.
EZRAW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -32.4%+0.8pp | -50.5%-20.1pp | -156.8% | -76.8%-41.4pp | -33.2% | -30.5% | -14.9%+28.9pp | -35.5%+22.1pp |
| Net Margin | -38.4%+2.6pp | -53.0%-10.5pp | -46.3%-22.0pp | -87.8%-41.8pp | -41.0% | -42.4% | -24.3%-20.1pp | -46.1%-13.0pp |
| Return on Equity | -19.8%+46.5pp | -21.5%+25.1pp | -17.2%+12.5pp | -88.0%-36.4pp | -66.4%+206.2pp | -46.7%+79.7pp | -29.7%-28.7pp | -51.5%-43.4pp |
| Return on Assets | -10.7%-0.4pp | -10.2%-2.1pp | -7.4%-2.6pp | -15.0%-6.9pp | -10.3%+20.2pp | -8.1%+31.1pp | -4.8%-4.4pp | -8.1%-5.1pp |
| Current Ratio | 2.40+1.4x | 1.78+0.7x | 1.47+0.3x | 1.42+0.3x | 0.980.0x | 1.12-0.3x | 1.13-0.1x | 1.16-0.3x |
| Debt-to-Equity | 0.53-2.9x | 0.63-2.5x | 0.69-2.8x | 2.80-0.8x | 3.46-2.0x | 3.16+1.6x | 3.51+2.7x | 3.56+2.7x |
| Liabilities-to-Equity | 0.86-4.6x | 1.11-3.7x | 1.32-3.9x | 4.84-0.5x | 5.43-2.5x | 4.78+2.6x | 5.18+3.9x | 5.35+3.7x |
| Asset Turnover | 0.280.0x | 0.190.0x | 0.160.0x | 0.170.0x | 0.250.0x | 0.190.0x | 0.20+0.1x | 0.18+0.1x |
| FCF Margin | N/A | -62.2%-35.8pp | -32.9%-10.8pp | -27.8%-6.5pp | 4.5%+9.8pp | -26.5%-1.4pp | -22.1%-82.6pp | -21.3%+8.4pp |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.
Where Reliance Global Group, Inc. Series A Warrants Ranks
Frequently Asked Questions
Reliance Global Group, Inc. Series A Warrants (EZRAW) reported $12.4M in total revenue for fiscal year 2025. This represents a -11.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Reliance Global Group, Inc. Series A Warrants (EZRAW) revenue declined by 11.6% year-over-year, from $14.1M to $12.4M in fiscal year 2025.
No, Reliance Global Group, Inc. Series A Warrants (EZRAW) reported a net loss of $7.0M in fiscal year 2025, with a net profit margin of -56.2%.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had EBITDA of -$7.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Reliance Global Group, Inc. Series A Warrants (EZRAW) had $1.3M in cash and equivalents against $4.1M in long-term debt.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had an operating margin of -72.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had a net profit margin of -56.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Reliance Global Group, Inc. Series A Warrants (EZRAW) has a return on equity of -108.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Reliance Global Group, Inc. Series A Warrants (EZRAW) recorded an outflow of $3.1M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Reliance Global Group, Inc. Series A Warrants (EZRAW) recorded an outflow of $3.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had $13.5M in total assets as of fiscal year 2025, including both current and long-term assets.
Reliance Global Group, Inc. Series A Warrants (EZRAW) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had a current ratio of 1.78 as of fiscal year 2025, which is generally considered healthy.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had a debt-to-equity ratio of 0.63 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had a liabilities-to-equity ratio of 1.11 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Reliance Global Group, Inc. Series A Warrants (EZRAW) had a return on assets of -51.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
At the end of fiscal year 2025, Reliance Global Group, Inc. Series A Warrants (EZRAW) held $1.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.1M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Reliance Global Group, Inc. Series A Warrants (EZRAW) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Reliance Global Group, Inc. Series A Warrants (EZRAW) reported a net loss of $7.0M while operations used $3.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Reliance Global Group, Inc. Series A Warrants (EZRAW) reported an operating loss of $9.0M against $1.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.